{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:41:15Z","timestamp":1778283675509,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.bcp.2009.04.025","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T08:35:06Z","timestamp":1241512506000},"page":"382-389","source":"Crossref","is-referenced-by-count":17,"title":["An inhibitor of Janus kinase 2 prevents polycythemia in mice"],"prefix":"10.1016","volume":"78","author":[{"given":"Anjili","family":"Mathur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Rung","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"O\u2019Hare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Kopinja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianlu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Aleksandrowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2009.04.025_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.seminhematol.2005.08.003","article-title":"Polycythemia vera: scientific advances and current practice","volume":"42","author":"Tefferi","year":"2005","journal-title":"Semin Hematol"},{"issue":"24","key":"10.1016\/j.bcp.2009.04.025_bib2","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"issue":"7037","key":"10.1016\/j.bcp.2009.04.025_bib3","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.bcp.2009.04.025_bib4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bcp.2009.04.025_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2009.04.025_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.0954-6820.1962.tb07186.x","article-title":"Complications and causes of death in polycythaemia vera","volume":"172","author":"Chievitz","year":"1962","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1016\/j.bcp.2009.04.025_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bcp.2009.04.025_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.bcp.2009.04.025_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/028418602317314064","article-title":"Symptoms, symptom distress and health-related quality of life in patients with polycythaemia vera or essential thrombocythaemia during treatment with interferon-alpha","volume":"41","author":"Merup","year":"2002","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.bcp.2009.04.025_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2141.2001.03161.x","article-title":"Pruritus in polycythaemia vera: prevalence, laboratory correlates and management","volume":"115","author":"Diehn","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bcp.2009.04.025_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2006-12-064287","article-title":"Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia","volume":"110","author":"Vannucchi","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2009.04.025_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.22365","article-title":"The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients","volume":"109","author":"Mesa","year":"2007","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2009.04.025_bib13","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1182\/blood-2005-08-3526","article-title":"Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia","volume":"107","author":"Schafer","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2009.04.025_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4065\/78.2.174","article-title":"Polycythemia vera: a comprehensive review and clinical recommendations","volume":"78","author":"Tefferi","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2009.04.025_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","article-title":"Signaling through the JAK\/STAT pathway, recent advances and future challenges","volume":"285","author":"Kisseleva","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2009.04.025_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1101\/SQB.1995.060.01.012","article-title":"The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction","volume":"60","author":"Lodish","year":"1995","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"12","key":"10.1016\/j.bcp.2009.04.025_bib17","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V98.12.3261","article-title":"Ineffective erythropoiesis in Stat5a(\u2212\/\u2212)5b(\u2212\/\u2212) mice due to decreased survival of early erythroblasts","volume":"98","author":"Socolovsky","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2009.04.025_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1043-2760(98)00101-5","article-title":"The erythropoietin receptor: structure, activation and intracellular signal transduction","volume":"10","author":"Constantinescu","year":"1999","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bcp.2009.04.025_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a\u2212\/\u22125b\u2212\/\u2212 mice: a direct role for Stat5 in Bcl-X(L) induction","volume":"98","author":"Socolovsky","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2009.04.025_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2009.04.025_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor","volume":"83","author":"Wu","year":"1995","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bcp.2009.04.025_bib22","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.04.025_bib23","doi-asserted-by":"crossref","first-page":"pe18","DOI":"10.1371\/journal.pone.0000018","article-title":"Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F","volume":"1","author":"Zaleskas","year":"2006","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2009.04.025_bib24","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.bcp.2009.04.025_bib25","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-06-2210","article-title":"Characterization of murine JAK2V617F-positive myeloproliferative disease","volume":"66","author":"Bumm","year":"2006","journal-title":"Cancer Res"},{"issue":"52","key":"10.1016\/j.bcp.2009.04.025_bib26","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.0509714102","article-title":"Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation","volume":"102","author":"Lu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.bcp.2009.04.025_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1358\/dnp.2005.18.5.904198","article-title":"JAK protein kinase inhibitors","volume":"18","author":"Thompson","year":"2005","journal-title":"Drug News Perspect"},{"issue":"8","key":"10.1016\/j.bcp.2009.04.025_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0960-894X(02)00106-3","article-title":"Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor","volume":"12","author":"Thompson","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.bcp.2009.04.025_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.leu.2404081","article-title":"JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders","volume":"20","author":"Quentmeier","year":"2006","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.bcp.2009.04.025_bib30","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1074\/jbc.M600064200","article-title":"Activated Jak2 with the V617F point mutation promotes G1\/S phase transition","volume":"281","author":"Walz","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bcp.2009.04.025_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood.V80.2.352.352","article-title":"Large, chronic doses of erythropoietin cause thrombocytopenia in mice","volume":"80","author":"McDonald","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2009.04.025_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbrc.2005.11.034","article-title":"The prolonged half-lives of new erythropoietin derivatives via peptide addition","volume":"339","author":"Lee","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.bcp.2009.04.025_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM199802263380902","article-title":"Expression of Bcl-x in erythroid precursors from patients with polycythemia vera","volume":"338","author":"Silva","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bcp.2009.04.025_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1182\/blood-2006-11-056465","article-title":"Erythropoietin modulation of podocalyxin and a proposed erythroblast niche","volume":"110","author":"Sathyanarayana","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2009.04.025_bib35","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2005-06-2304","article-title":"AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation","volume":"107","author":"Ghaffari","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bcp.2009.04.025_bib36","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V98.10.2948","article-title":"Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(\u2212\/\u2212) hematopoietic progenitors","volume":"98","author":"Ghaffari","year":"2001","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.bcp.2009.04.025_bib37","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines","volume":"282","author":"Schindler","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.bcp.2009.04.025_bib38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2005-10-009514","article-title":"Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells","volume":"108","author":"Gar\u00e7on","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcp.2009.04.025_bib39","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","article-title":"TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bcp.2009.04.025_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2005.05580.x","article-title":"Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor","volume":"130","author":"Arcasoy","year":"2005","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bcp.2009.04.025_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2009.04.025_bib42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1074-7613(00)00054-6","article-title":"Partial impairment of cytokine responses in Tyk2-deficient mice","volume":"13","author":"Karaghiosoff","year":"2000","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2009.04.025_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1074-7613(00)00055-8","article-title":"Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function","volume":"13","author":"Shimoda","year":"2000","journal-title":"Immunity"},{"issue":"5237","key":"10.1016\/j.bcp.2009.04.025_bib44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.270.5237.800","article-title":"Defective lymphoid development in mice lacking Jak3","volume":"270","author":"Nosaka","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bcp.2009.04.025_bib45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/1074-7613(95)90066-7","article-title":"Developmental defects of lymphoid cells in Jak3 kinase-deficient mice","volume":"3","author":"Park","year":"1995","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bcp.2009.04.025_bib46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/01.tp.0000177643.05739.cd","article-title":"Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts","volume":"80","author":"Paniagua","year":"2005","journal-title":"Transplantation"},{"issue":"1 Suppl. 2","key":"10.1016\/j.bcp.2009.04.025_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0037-1963(01)90136-2","article-title":"Evaluation of diagnostic criteria in polycythemia vera","volume":"38","author":"Pearson","year":"2001","journal-title":"Semin Hematol"},{"issue":"10","key":"10.1016\/j.bcp.2009.04.025_bib48","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2009.04.025_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bcp.2009.04.025_bib50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/cc.6.5.3919","article-title":"Oncogenes in myeloproliferative disorders","volume":"6","author":"Tefferi","year":"2007","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.bcp.2009.04.025_bib51","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","article-title":"The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3","volume":"109","author":"Hookham","year":"2007","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.bcp.2009.04.025_bib52","doi-asserted-by":"crossref","first-page":"16930","DOI":"10.1073\/pnas.0604902103","article-title":"Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo","volume":"103","author":"Kennedy","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209003347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209003347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:55:28Z","timestamp":1589756128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209003347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0006295209003347"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.04.025","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}